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Abstract 
The issue of studying features of endothelial dysfunction of vessels in patients with arterial hypertension 
(AH) and different cardiovascular risk remains essential. While studying two groups of patients with 
moderate and a high risk for developing cardiovascular conditions it has been determined that, body mass 
index (BMI) increased significantly more expressed in the group with AH with the high risk for 
cardiovascular conditions (p<0.01 in comparison with the first group). Ratio WC/HC and WC/height 
exceeds the recommended indices, which confirms the presence of overweight in the main part of the 
studied patients in general. DBP in the second group has been reliably higher than the indices of the first 
group (p<0.001). The average value of TC exceeds the recommended values, level of high-density 
lipoproteins (HDL) has been confirmed to be different in both groups at the beginning of the research and 
it has been higher in the first group (р<0.05). In the group of the high risk, irrefutable increase in 
endothelin-1 (ET-1) and vWF (von Willebrand factor) has been observed compared to indices in the 
group with a moderate risk (р<0.001), which testifies to more expressed vasoconstriction and progressive 
blood clots in vessels. 
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Introduction 
Despite the increase in control over arterial pressure around the world, the increase in a 
number of patients with hypertonic disease alarms. Further study of clinical-functional features 
of AH in patients with different clinical groups with the research on ways of correcting not 
only arterial hypertension itself but also associated microcirculatory, endothelial and metabolic 
disorders with determination of additional organs-targets with the development of the 
differentiated approach to therapy and evaluation of anti-hypertension treatment effectiveness 
criteria, remains actual [4]. 
The issue of studying features of endothelial dysfunction of vessels in patients with AH and 
different cardiovascular risk is of current importance [5]. Vulnerability of endothelial cells to 
pathogenic factors of the system blood flow is defined by their unique position on the edge 
between circulating blood and tissues. Dysfunction of endothelium causes disorder in control 
over vascular tone, blood clots, fibrinolysis [1, 3]. 
According to Framingham study, the main factors of endothelial dysfunction of arteries are 
increased body mass index (BMI), AH, age, smoking, dyslipidemia, DM and so on, they 
intensify the processes of oxidative stress, which violates the balance between protective and 
damaging influence on the vascular wall and leads to initiation and progression of pathological 
changes in vessels [7]. 
 
The purpose of the research is to study features of endothelial dysfunction in patients with 
AH, associated with a moderate and a high risk for cardiovascular conditions. 
 
Materials and methods. 
102 patients with DM 2 type aged 42-73 were under observation; they were distributed into 
two groups by the risk for development of cardiovascular conditions: I group – 48 patients 
with AH and a moderate risk, II group – 54 patients with AH and a high cardiovascular risk 
(DM 2 type). Among the studied patients 34 (33.3%) were men and 68 (66.7%) women. 
Average duration of AH was 10.09±0.59 years. 
Both groups of patients were compared by gender, age and duration of AH – in all 
comparisons р>0.05 (Table 1).
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Table 1: General and clinical characteristics of patients of main groups at the beginning of the research (M±m) 
 
Index Total (n=102) I group (n=48) II group (n=54) р between groups 
Gender males 34 (33.3%) 19 (39.6%) 15 (27.8%) >0.05 females 68 (66.7%) 29 (60.4%) 39 (72.2%) 
Age, years 56.2±0.62 55.4±0.95 56.9±0.80 >0.05 
BMI, kg/m2 27.8±0.23 27.1±0.37 28.4±0.25 <0.01 
Duration of AH, years 10.09±0.59 9.48±0.77 10.64±0.88 >0.05 
Duration of DM, years 4.89±0.40 – 4.89±0.40 <0.001 
 
The control group was 15 clinically healthy by the main 
disease people who were compared by age (average age was 
58.0±1.2 years old; р>0.05) and gender (6 males and 9 
females; р>0.05). Level of endothelin-1 (ЕТ-1) in blood of 
practically healthy people was 0.37±0.06 fmol /ml, vWF - 
0.7±0.2 U/ml, triglycerides 2.5±0.07 ng/ml, which is 
considered to be a norm for the region. 
The level of AH in patients of both groups corresponded to 
criteria of moderate and high AH, according to 
recommendations of Annual European Conference on Arterial 
Hypertension, edited and amended in 2013. [2, 6].  
Apart from general clinical examination, the following special 
clinical-laboratory parameters have been studied: 
concentration in blood serum of markers of endothelial 
dysfunction (endothelin-1, trombomodulin and von Willebrand 
factor), concentration of total cholesterol (TC), high and low 
density lipoprotein cholesterol (HDL and LDL), triglycerides 
(TG) and atherogenic index (АI), calculated according to the 
well-known formula for TC and HDL. Besides the speed of 
glomerular filtration rate (GFR) and levels of creatinine and 
urea have been estimated. All laboratory examinations have 
been carried out considering recommendations of manu-
facturing companies based on contemporary principles of 
laboratory technologies. Immunoassay analysis of markers of 
endothelial dysfunction (ED) was carried out on the base of 
the diagnostic center of LLC “Apteky Medychnoyi 
Academiyi” (Dnipropetrovsk) with the help of reagent kits 
made by “Technoclone GmBh” and “Biomedica Medizin-
producte” (Austria). 
Statistic processing of results of the research has been done 
with the help of the licensed software Statistica, version 6.1®. 
Reliability assessment of differences between means has been 
carried out according to Student’s test (t) considering homo or 
heteroskedasticity variance (Fisher's exact test), relative 
measures – Pearson's chi-squared test (2).  
 
Results and discussions. 
Level of systolic blood pressure (SBP) in the first group was 
166.9±0.6 mmHg, in the second group – 167.7±0.8 mm Hg, 
without reliable differences between them (р>0.05) (Table 2). 
At the same time, indices of diastolic blood pressure (DBP) in 
patients with AH and a high cardiovascular risk were 6.0 
mmHg or 7.5% higher than those of the patients from the first 
group (р<0.001).  
 
Table 2: Level of arterial pressure in patients of main groups at the 
beginning of the research (M±m) 
 
Index I group (n=48) II group (n=54) р between groups 
SBP, mmHg 166.9±0.60 167.7±0.83 >0.05 
DBP, mmHg 79.7±1.20 85.7±1.05 <0.001 
 
One of the major predictors of developing cardiovascular 
conditions is overweight. BMI on average was 27.8±0.23 
kg/m2, which means overweight in all groups of the studied 
patients (Table 1). At that in the group with AH and DM 2 
type BMI was 4.8% higher than indices of the first group 
(p<0.01), which implies additional factor of developing 
cardiovascular conditions.  
It is worth noting that in case of sportsmen, children and 
gender BMI does not necessarily define overweight. Among 
additional parameters are indices of waist circumference (WC) 
and hip circumference (HC), height and their ratio WC/HC, 
WC/height. The recommended waist circumference for 
evaluating the distribution of fat tissue in women is 80 cm, in 
men – 94 cm. Indices higher than 88 cm in women and 102 cm 
in men indicate a higher risk of developing cardiovascular 
complications and diabetes mellitus in future (WHO, 1997). 
According to the results of our research indices of WC in 
women of both groups significantly exceed the norm – 
98.0±2.06 cm in the first group and 97.1±1.13 cm in the 
second group (р>0.05 between groups) (Table 3).  
 
Table 3: Indices of WC, height and their ratio depending on gender 
of patients in main groups at the beginning of the research (M±m) 
 





WC males 94.5±1.9 95.9±1.51 >0.05 females 98.0±2.06 97.1±1.13 >0.05 
WC/HC males 0.91±0.010 0.89±0.015 >0.05 females 0.85±0.009 0.88±0.007 <0.01 
WC/height males 0.54±0.011 0.55±0.008 >0.05 females 0.60±0.014 0.60±0.007 >0.05 
 
Ratio WC/HC characterizes the possibility of developing 
abdominal overweight as a predictor of developing cardio-
vascular conditions in future. In females of the second group 
ratio WC/HC was 3.5% higher than that one of the first group- 
0.88±0.007 compared to 0.85±0.009 (р<0.01). Overall the 
increase in norms of ratio WC/HC was observed in 42.2% (43 
patients) cases, including in the first group- 22.9% (11 patients 
out of 48), in the second group – 59.3% (32 out of 54 patients) 
(р<0.001 between groups), which indicates additional risk 
factor in patients with AH, especially in combination of AH 
with DM 2 type.  
Ratio WC/height is another sign of abdominal obesity. It is 
even more qualitative than BMI, since while calculating 
features of skeleton, muscular features of a certain person, 
distribution of fat tissue are not considered. Normal ratio is 
0.42-0.49 for women and 0.43-0.53 for men. The increase in 
its value means overweight. At the beginning of the research 
this index was higher than norm in 55.9% males (19 out of 34) 
and in 97.1% females (66 out of 68), without reliable 
differences between the studied groups (р>0.05) (Table 3). 
Thus during estimation of indices of abdominal obesity as an 
additional factor of developing cardiovascular conditions, we 
can note that BMI is increased both in the first and in the 
second group, but it is more expressed in the group of AH with 
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a high risk for cardio-vascular conditions (p<0.01 compared to 
the first group). Ratio WC/HC, WC/height exceeds the 
recommended indices, which confirms overweight in the main 
part of the studied patients in general. In the process of 
observation the patients are reasonable to be recommended to 
control their weight.  
All patients at the stage of the research had general clinical, 
laboratory and special methods of examination. 
Level of Hb in the first group at the beginning of the research 
was 130.6±0.51 g/l, in the second group – 135.9±1.91 g/l, and 
was reliably different (р<0.05 according to Student’s test), 
however, clinically significant decrease of index compared to 
norm has not been determined in any group (Table 4). 
 
Table 4: Level of Hemoglobin in patients of main groups at the 
beginning of the study (M±m) 
 







Hb, g/l 133.4±1.07 130.6±0.51 135.9±1.91 <0.05 
 
The direct and indirect inclusion of dyslipidemia into the 
mechanism of development and progression of ED has been 
confirmed. Therefore all patients were examined by the lipid 
profile in dynamics of the research (Table 5). 
 
Table 5: Level of indices of lipid profile in patients of main groups at 
the beginning of the research (M±m) 
 







TC, mmol/l 5.57±0.10 5.70±0.12 5.46±0.16 >0.05 
HDL, mmol/l 1.29±0.03 1.35±0.05 1.23±0.04 <0.05 
LDL, mmol/l 3.35±0.08 3.44±0.11 3.28±0.12 >0.05 
TG, mmol/l 2.00±0.09 1.82±0.10 2.16±0.15 >0.05 
АI 3.50±0.11 3.42±0.17 3.57±0.15 >0.05 
 
At the initial stage of the research the analysis of lipid profile 
did not determine statistically significant differences in 
patients of the first and second groups by the level of TC: in 
the first group this index was 5.70±0.12 mmol/l, in the second 
group – 5.46±0.16 mmol/l (p>0.05). The average value of TC 
by groups was 5.57±0.10 mmol/l, which exceeds the values 
indicated by recommendations of ESC (2013) [2, 5]. 
Level of HDL reliably differs in two groups of the research 
and it was 9.8% higher in the first group (р<0.05), which 
indicates more expressed antiatherogenic features and less 
progressive dysfunction of endothelium in future (Table 5).  
Level of cholesterol LDL in both groups was high – 3.44±0.11 
mmol/l in the first group and 3.28±0.12 mmol/l in the second 
group but without reliable differences between them (р>0.05).  
Level of TG at the beginning of the research in the second 
group was increased (2.16±0.15 mmol /l) compared to patients 
of the first group (1.82±0.1 mmol/l) with р=0.061 according to 
Student’s test, which characterizes DM as the predictor of a 
high risk of cardiovascular condition.  
Index АI has been estimated based on TC and HDL, therefore 
it is directly connected with these indices. In the first group 
this index was 3.42±0.17, in the second group – 3.57±0.15 
without reliable differences (р>0.05). (Table 5) Since the 
defining index in calculation of this index is HDL, despite the 
fact that TC is higher in the first group, АI is higher in the 
group with a high cardiovascular risk. 
Renal excretory function has been estimated for 12 months 
with the help of glomerular filtration rate (GFR) as well as 
with the help of additional indices – urea and creatinine. The 
function of kidneys has been preserved, it has been proved by 
the following data: GFR as the most sensitive index of 
functional and tissue work of kidneys in the first group was 
86.4±1.89 ml/min./1.73m2, in the second group – 86.1±1.95 
ml/min/1.73m2 without reliable differences between them 
(р>0.05). 
Level of urea in blood serum in the first group was – 
5.85±0.23 mmol/l, in the second group – 5.97±0.19 mmol/l 
(Table 6). No reliable differences between groups were 
revealed (р>0.05). 
 
Table 6: Biochemical indices of kidney metabolism in patients of 
main groups at the beginning of the research (M±m) 
 





Urea, mmol/l 5.85±0.23 5.97±0.19 >0.05 
Creatinine, mkmool/l 81.6±2.27 73.5±2.17 <0.05
GRF, ml/min/1.73m2 86.4±1.89 86.1±1.95 >0.05 
 
The second marker of renal work is creatinine. In the first 
group it was 81.6±2.3 mkmol/l, in the second group – 73.5±2.2 
mkmol/l, which is 8.1 mkmol/l, or 11.0% higher in the first 
group (р<0.05). However, the increase of the index above 
norm has not been noticed.  
Specific markers for defining endothelial function of vessels in 
our research were: endothelin-1 (ЕТ-1), vWF and 
thrombomodulin. In the group of a high risk, reliable increase 
of ЕТ-1 and vWF (р<0.001) has been noticed compared to 
groups with moderate risk (Table 7). 
 
Table 7: Level of markers of ED of all studied groups of patients at 
the beginning of the research (M±m) 
 








ЕТ-1, fmol/ml 1.29±0.11 0.87±0.048 1.66±0.198 <0.001
Thrombomodulin, 
ng/ml 3.32±0.09 3.27±0.121 3.37±0.133 >0.05 
vWF, U/ml 1.05±0.03 0.95±0.037 1.17±0.029 <0.001 
 
ЕТ-1 in the first group was 0.87±0.048 fmol/ml, in the second 
1.66±0.198 fmol/ml, average index by groups was 1.29±0.11 
fmol/ml. The groups were reliably different by the level of ЕТ-
1 (р<0.001 according to Student’s test), which indicates strong 
vasoconstriction of vessels in the group with a high 
cardiovascular risk at the beginning of the research. 
Thrombomodulin in the first group at the beginning of the 
research was 3.27±0.121 ng/ml, in the second one – 
3.37±0.133 ng/ml. Despite the fact that this marker is 
responsible for athrombogenic features of the vascular wall, 
binding thrombin and later it significantly changes its features, 
there were no evident reliable differences between groups 
(р>0.05 according to Student’s test).  
Von Willebrand factor in the first group was 0.95±0.04 U/ml, 
in the second group 1.17±0.03 U/ml (р<0.001 according to 
Student’s test). The reliable exceed of this factor grounds the 
intensified influence of AH with a high risk for cardiovascular 
conditions in the vascular wall. 
 
Conclusions 
1. Increasing BMI is more pronounced in the hypertensive 
group at high risk of cardiovascular events (p<0,01 
compared with the first group). Ratio WC/HC, WC/height 
exceeds the recommended indices, it confirms the 
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overweight in the main part of the studied patients in 
general. In the process of observation, it has been 
concluded that IT is reasonable to control the weight of the 
body. 
2. DBP in the second group at the beginning of the research 
was reliably higher than that of the first group (p<0.001), 
which indicates vascular changes in the group with a high 
cardiovascular risk.  
3. The mean value of TC by groups is 5.57±0.10 mmol/l, 
which exceeds values recommended by ESC (2007), and it 
is an additional factor of cardiovascular conditions in 
future. 
4. The level of HDL in the first group is 1,35±0,05 mmol/L, 
the second - 1,23±0,04 mmol/L, indicating a more 
pronounced antiatherogenic properties and less progression 
of endothelial dysfunction in the future (p < 0.05) in a 
group with moderate risk of cardiovascular events. 
5. In the group of a high risk, the reliable exceed in ЕТ-1 and 
vWF has been revealed compared to indices of the group 
with a moderate risk (р<0.001), which indicates more 
expressed vascular constriction and progressing blood clots 
in vessels. 
6. Prospect for further research is connected with dynamic 
monitoring over indicators of ED markers in the selected 
groups of patients, administration of anti-hypertensive 
medicines and analysis of their influence on endothelium 
of vessels within twelve months. 
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